• (54) 234 567 789
  • info@example.com

    Building Consumer Ecosystems, Informed by Data, Powered by Technology

    ClearVue Partners is a private equity firm focused on the consumer sector of China, investing in fast growing companies that are informed by data, and powered by technology. We invest along the consumer megatrend themes of modernization & new retail, lifestyle, health & wellness, and the digital consumer. We target growth stage investments in fast growing and promising local companies, enable market entry for leading international consumer brands into China, and develop top tier brands and businesses. Our team has a unique combination of investment and senior operations experience from the US and Greater China with an advisory group of recognized business pioneers in the consumer industry. We believe in operational value add for our portfolio investments, and bring global and multi-national best practices and relationships to rapidly growing companies in China.

    CLEARVUE NEWS

    Harry Hui joined the Business Talk show on Shanghai TV

    Harry Hui joined the business talk show “Life of Pure Pleasure” on Shanghai TV. Harry was invited as an important investor in PE industry in Shanghai and shared his life in the investment industry dur

    Harry Hui was a keynote speaker at the IMA Asia CEO Forum

    Harry Hui was invited as a keynote speaker at the IMA Asia CEO Forum in Shanghai. IMA Asia is an insights provider and runs the region’s leading peer group forums for senior executives, with over 1,5

    William Chen shared insights at the AccessAlts Asia Alternatives Summit 2018 in New York

    William Chen joined the AccessAlts Asia Alternatives Summit 2018 in New York in March. Will participated as a conference panelist and shared his insights on China PE market latest developments and his

    PORTFOLIO NEWS

    Ping An's Good Doctor unit raises $1.1 billion in Hong Kong

    2018-06-09

    HONG KONG (Reuters) - Ping An’s Good Doctor online healthcare platform has raised $1.12 billion in its initial public offering, pricing its shares at the top of its range in Hong Kong’s largest new li